XYZAL ORAL SOLUTION

Compare XYZAL ORAL SOLUTION  to:
Compare
Compare
XYZAL (levocetirizine) 0.5mg/mL oral solution by UCB and Sanofi Aventis

Generic Name for XYZAL ORAL SOLUTION

Levocetirizine dihydrochloride 0.5mg/mL.

Legal Classification:

Rx

Pharmacological Class for XYZAL ORAL SOLUTION

Antihistamine.

Manufacturer of XYZAL ORAL SOLUTION

UCB and Sanofi Aventis

Indications for XYZAL ORAL SOLUTION

Seasonal allergic rhinitis (for patients ≥2 years old). Perennial allergic rhinitis, chronic idiopathic urticaria (for patients ≥6 months old).

Adult dose for XYZAL ORAL SOLUTION

2.5mg–5mg once daily in the PM. Renal dysfunction: CrCl 50–80mL/min: 2.5mg once daily; CrCl 30–50mL/min: 2.5mg every other day; CrCl 10–30mL/min: 2.5mg twice per week (every 3–4 days); CrCl <10 mL/min or hemodialysis: contraindicated.

Children's dosing for XYZAL ORAL SOLUTION

<6mos: not recommended. 6mos–5yrs: max 1.25mg once daily in the PM. 6–11yrs: max 2.5mg once daily in the PM. Renal dysfunction: contraindicated.

Also:

Contraindications for XYZAL ORAL SOLUTION

End-stage renal disease (CrCl <10mL/min) or hemodialysis. Impaired renal function (<12yrs of age).

Precautions for XYZAL ORAL SOLUTION

Do not exceed recommended dose. Pregnancy (Cat.B). Nursing mothers: not recommended.

Interactions for XYZAL ORAL SOLUTION

Avoid alcohol, other CNS depressants. May be potentiated by theophylline. Potentiated by ritonavir.

Adverse Reactions for XYZAL ORAL SOLUTION

Adults: somnolence, nasopharyngitis/pharyngitis, fatigue, dry mouth. Children: pyrexia, somnolence, cough, epistaxis, diarrhea, vomiting, otitis media.

How is XYZAL ORAL SOLUTION supplied?

Tabs—90
Soln—150mL

Related Disease:

Allergic rhinitis~systemic products
Allergy~systemic antiallergic drugs
Urticaria~antihistamines

Related Resources

Claritin 12-Hour RediTabs available for allergies

September 01, 2009

Schering-Plough has expanded the Claritin product line with the introduction of Claritin 12-Hour RediTabs (loratadine), a non-drowsy antihistamine in a quick dissolving tablet.

Children's Zyrtec Perfect Measure and Zyrtec Itchy Eye Drops available for allergies

August 25, 2009

McNeil Consumer Healthcare has expanded the Zyrtec product line with the introduction of Children's Zyrtec Perfect Measure (cetirizine HCl syrup) and Zyrtec Itchy Eye Drops (ketotifen fumarate ophthalmic solution).

Xyzal gains expanded pediatric indication

August 24, 2009

The FDA has approved an expanded pediatric indication for Xyzal (levocetirizine dihydrochloride, from UCB and Sanofi-aventis) to include the relief of symptoms associated with perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children ≥6 months of age.

Leukotriene modifier drug label change requested by FDA

June 16, 2009

The FDA has requested that manufacturers of leukotriene modifiers include a precaution in the drug labeling regarding neuropsychiatric events that have been reported in some patients taking montelukast (Singulair, from Merck), zafirlukast (Accolate, from AstraZeneca) and zileuton (Zyflo CR from Cornerstone Therapeutics).

New Children's Zyrtec Allergy Syrup flavor available

January 27, 2009

McNeil Consumer Healthcare has expanded its line of Zyrtec (cetirizine HCL) products with the introduction of Children's Zyrtec Allergy Bubble Gum Syrup, a sugar-free, dye-free medication.